NDC 84269-2546-01 - Sinu-Phen Plus Sinus Pain and Pressure
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 84269-2546
- Requested NDC
- 84269-2546-01
- Package NDCs from labels
- 84269-2546-2, 84269-2546-1, 84269-2546-01
- Manufacturer
- Wildman Business Group | Allegiant Health | Medique Products | Prestige Packaging
- Effective date
- 2026-01-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE - Wildman Business Group | Allegiant Health | Medique Products | Prestige Packaging | Wildman Business Group | Allegiant Health | Medique Products | Prestige Packaging | 2026-01-12 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84269-2546-1 | Sinu-Phen Plus Sinus Pain and Pressure | 50 in 1 BOX | TABLET | 50 | 2 | |
| 84269-2546-1 | Sinu-Phen Plus Sinus Pain and Pressure | 2 in 1 PACKET | TABLET | 2 | 2 | |
| 84269-2546-2 | Sinu-Phen Plus Sinus Pain and Pressure | 2 in 1 PACKET | TABLET | 2 | 2 | |
| 84269-2546-2 | Sinu-Phen Plus Sinus Pain and Pressure | 125 in 1 BOX | TABLET | 125 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 84269-2546 | SINU-PHEN PLUS SINUS PAIN AND PRESSURE (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET [WILDMAN BUSINESS GROUP] | 1 | Current NDC, 4 package rows | 20240701_c66e0b52-5531-4a84-ae90-8a26d27df1ec.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.